Research
Energy balance
82.5% of Efsubaglutide-treated participants achieved ≥5% weight loss.
A significant proportion of individuals treated with Efsubaglutide Alfa can expect to achieve clinically meaningful weight loss.
StrongSupportsmedium confidence
Overall, 82.5% of Efsubaglutide-treated participants achieved ≥5% weight loss (vs. 0% placebo).
Why this rating
Based on the randomized, double-blind, placebo-controlled trial design.
Source
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( <scp>LIGHT</scp> 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
Fei Gao et al. · Diabetes Obesity and Metabolism · 2026
rct · n=50
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →